hypertriglyceridemia in unani medicine
Phase 2
- Conditions
- Health Condition 1: E785- Hyperlipidemia, unspecified
- Registration Number
- CTRI/2019/02/017498
- Lead Sponsor
- ational Institute Of Unani MedicineNIUM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Age between 35-60 years
2.Patients of both the genders
3.Central Obesity: Waist Circumference > 90 cm in Male, >80 cm in Female
4.Hypertriglyceridemia: Triglycerides <499 mg/dl 5. Cases of hypertension with (Pre-hypertensive stage i.e. 120-139 systolic/80-89 diastolic)
6.Fasting Blood Glucose: 126 - < 200mg/dl
7.Postprandial Blood Glucose Level: >140 - <300 mg/dl
8.Patient not taking treatment for Hypertriglyceridemia (Statins)
Exclusion Criteria
1.K/c/o Systemic diseases
2.Pregnant and Lactating women
3.Type-1 Diabetes
4.Patients on weight loss medication
5.Fasting Plasma Glucose >=200mg/dl
6.BP >=139/89 mmHg
7.Patients on treatment for Hypertriglyceridemia (Statins)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effect on triglycerides level (Normal / Decrease in TGL level)Timepoint: 0th day, 15th day, 30th day, 45th day, 60th day.
- Secondary Outcome Measures
Name Time Method i)Effect on hyperglycemia (Decrease in glucose / HbA1c level) ii)Effect on HDLTimepoint: 0th day, 15th day, 30th day, 45th day, 60th day.